Business of Bioanalysis: The Inherent Risk in Depending on a Single Platform

Watch Dr. Afshin Safavi, BioAgilytix Global CSO discuss how common it is for those of us in the bioanalytical industry to depend on a single vendor for a project’s platform as part of the “Business of Bioanalysis” panel hosted by Bioanalysis Zone.

*Video Produced by Bioanalysis Zone

Share This